Skip to Main content Skip to Navigation
Journal articles

ELYPSE-7: a randomized placebo-controlled phase IIa trial with CYT107 exploring the restoration of CD4+ lymphocyte count in lymphopenic metastatic breast cancer patients

Keywords : Patients Breast
Document type :
Journal articles
Complete list of metadatas

https://hal-univ-lyon1.archives-ouvertes.fr/hal-01795705
Contributor : Lauriane Pillet <>
Submitted on : Friday, May 18, 2018 - 4:38:39 PM
Last modification on : Monday, August 31, 2020 - 9:52:06 AM

Links full text

Identifiers

Collections

Citation

O. Tredan, C. Menetrier-Caux, Isabelle Ray-Coquard, G. Garin, C. Cropet, et al.. ELYPSE-7: a randomized placebo-controlled phase IIa trial with CYT107 exploring the restoration of CD4+ lymphocyte count in lymphopenic metastatic breast cancer patients. Annals of Oncology, Elsevier, 2017, ⟨10.1093/annonc/mdx058⟩. ⟨hal-01795705⟩

Share

Metrics

Record views

71